JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A2977 Cabozantinib (XL184, BMS-907351)
3 Citation

Summary: VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor

≥25.08 mg/mL
A2251 Tivozanib (AV-951)

Target: VEGFR

Summary: VEGFR inhibitor,potent and selective

≥22.75 mg/mL
A1835 Pelitinib (EKB-569)

Summary: EGFR inhibitor,potent and irreversible

insoluble in EtOH; insoluble in H2O; ≥11.7 mg/mL
A5413 HMN-214

Summary: Plk inhibitor,broad-spectrum anti-tumor agent

≥21.2 mg/mL
A5639 BIRB 796 (Doramapimod)
5 Citation

Summary: P38 MAPK inhibitor,cell permeable and highly selective

≥26.4 mg/mL
A2547 Vortioxetine (Lu AA21004) HBr

Summary: 5-HT receptor modulator, antidepressant and anxiolytic

insoluble in H2O; ≥50 mg/mL
A8304 FR 180204

Target: ERK

Summary: ERK inhibitor

insoluble in H2O; ≥10.25 mg/mL
A8332 R788 disodium

Target: Syk

Summary: Syk inhibitor,ATP competitive and potent

≥62.4 mg/mL
A8333 Canagliflozin
5 Citation

Target: SGLT

Summary: SGLT2 inhibitor,potent and selective

≥22.25 mg/mL
A8340 Cyclopamine
8 Citation

Target: Smoothened

Summary: Hedgehog (Hh) signaling Inhibitor

insoluble in EtOH; insoluble in H2O; ≥6.86 mg/mL